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Pyocyanin (PCN), a virulence factor synthesized by Pseudomonas aeruginosa, plays an important role
during clinical infections. There is no study of the effect of nitric oxide (NO) on PCN biosynthesis. Here,
the effect of NO on PCN levels in Pseudomonas aeruginosa strain PAO1, a common reference strain, was
tested. The results showed that the NO donor sodium nitroprusside (SNP) can signiﬁcantly reduce PCN
levels (82.5% reduction at 60 μM SNP). Furthermore, the effect of endogenous NO on PCN was tested by
constructing PAO1 nor (NO reductase gene) knockout mutants. Compared to the wild-type strain, the
Δnor strain had a lower PCN (86% reduction in Δnor). To examine whether the results were universal
with other P. aeruginosa strains, we collected 4 clinical strains from a hospital, tested their PCN levels
after SNP treatment, and obtained similar results, i.e., PCN biosynthesis was inhibited by NO. These re-
sults suggest that NO treatment may be a new strategy to inhibit PCN biosynthesis and could provide
novel insights into eliminating P. aeruginosa virulence as a clinical goal.
& 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pseudomonas aeruginosa is a gram-negative bacillus that is ra-
pidly becoming one of the major causes of opportunistic and no-
socomial infections. Nosocomial infections caused by Pseudomonas
aeruginosa have become a worldwide problem. P. aeruginosa in-
fections are associated with increased mortality and morbidity,
particularly in susceptible patients with compromised imm-
une systems and cystic ﬁbrosis (CF); over 80% of CF patients die
from these infections [1]. P. aeruginosa is naturally resistant to a
large range of antibiotics (cephalosporins, carbapenems, ﬂuor-
oquinolones, and aminoglycosides) and may demonstrate addi-
tional resistance after unsuccessful treatment [2]. Some new
strategies have been developed because of unsatisfactory tradi-
tional antibiotic treatment, including inhibition of the pathogenic
factors of P. aeruginosa [3].
The main pathogenic factors of P. aeruginosa include elastase,
alkaline protease, LasA protease, hemolysin, rhamnolipids and
pyocyanin (5-methyl-1-hydroxyphenazine) (PCN) [4]. PCN, a blue
colored phenazine exotoxin, can easily penetrate biological
membranes and is found in the sputum of CF patients infected byn open access article under the CC
hen),P. aeruginosa [5]. Recent in vivo studies on alternative model hosts
[6] and mice [7] have revealed that PCN is a key compound in P.
aeruginosa infections and is a signiﬁcant contributor to lung de-
struction during chronic P. aeruginosa infection in patients with
bronchiectasis. PCN inhibits the ciliary beating of airway epithelial
cells and enhances superoxide production [8].
Nitric oxide (NO) not only is important as a biological mes-
senger but also has many biological effects [9]. Excessive exogen-
ous NO can damage proteins, nucleic acids, and cellular mem-
branes when the concentration of NO exceeds the capacity of cell
metabolism. Nitric oxide reductase (NOR) is a common respiratory
enzyme in eukaryotic cells and bacteria [10] that catalyzes the
endogenous NO to N2O. The enzyme is involved in the deni-
triﬁcation pathway of P. aeruginosa by dissimilatory nitrate re-
spiration [11]. If NO is not reduced by NOR to N2O, it may accu-
mulate, and its toxicity could compromise bacteria. Therefore, the
respiratory enzyme NOR is also a detoxifying enzyme. In other
words, the enzyme is involved in the defense against exogenous
NO in their surrounding natural habitats and within their hosts
[12]. This enzyme is part of a cytochrome bc-type complex in P.
aeruginosa. The norC and norB genes, encoding the cytochrome c
and cytochrome b subunits, respectively, are clustered with the
norD gene, which is required for the expression of the active NOR
enzyme [13].
Recent research has shown that a high concentration of NO can
inhibit the growth of E. coli [14]; however, sublethalBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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dispersal and helps in the bioﬁlm mode of growth transition to the
free-swimming planktonic state [15]. Is there any other effect of
NO on P. aeruginosa? Based on this question, we tested the PCN
biosynthesis of P. aeruginosa in the presence of different con-
centrations of the NO donor sodium nitroprusside (SNP). Both SNP
and nor gene knockout mutants could effectively inhibit the
synthesis of PCN in P. aeruginosa.2. Material and methods
2.1. Bacterial isolates
Four clinical isolates of P. aeruginosa were collected from Shanxi
Province People’s Hospital in China (Table 1). The P. aeruginosa strains
were isolated from urine (1) and sputum (3) samples. We also used
the reference PAO1 strain as the main lab strain. The PAO1 strain was
kindly provided by Professor Kangmin Duan (Department of Medical
Microbiology, University of Manitoba, Canada).
2.2. Growth test
A 10 ml overnight culture of PAO1 was grown in LB medium
(10% peptone, 5% yeast extract and 10% NaCl) at 37 °C on an orbital
shaker at 200 rpm. The OD600 nmwas adjusted to 0.1 using sterile
LB and vortexed. Then, 100 μl was added to culture tubes con-
taining 50 ml of LB medium. Next, sodium nitroprusside (SNP) was
added to the LB in the tubes at the desired concentrations. For the
untreated control, no SNP was added. The cultures were grown
aerobically at room temperature on an orbital shaker at 200 rpm
for 18–22 h. The growth was followed by measurement at
OD600 nm every 2 h.Table 1
List of strains and plasmids used in this study.
Strain or plasmid Characteristic(s)a
Strains
Escherichia coli
DH5α F- mcrA Δ(mrr-hs
lacZ ΔM15 ΔlacX
araD139 Δ(ara,leu
rpsL nupG tonA
Pseudomonas
aeruginosa
PAO1 Wild type, lab str
PAN1 nor insertion mut
PA515 Wild type, clinica
PAN515 nor insertion mut
PA196 Wild type, clinica
PA554 Wild type, clinica
PA914 Wild type, clinica
Plasmids
pEX18Amp oriTþsacBþ gene
with multiple-clo
AmpR
pHpΏ45 Smr/Spcr gene fro
transcription-term
from pMJK4-18 p
pZ1918Gm Source plasmid o
pRK2013 Broad-host-range
pEXB pEX18Amp conta
AmpR
pEXB1lacZ pEXB1 containing
from pZ1918Gm i
AmpR/GmR
a Antibiotic resistance markers: AmpR ampicillin, GmR gent2.3. DNA manipulations
Chromosomal and plasmid DNA extraction, puriﬁcation, enzy-
matic digestion, DNA ligation, and transformation of Escherichia
coli were performed according to standard methods [16]. PCR was
conducted using Taq polymerase (TaKaRa Japan) on an ABI PCR
system. The following PCR program was used: 5 min at 95 °C and
30 cycles of 30 seconds at 95 °C, 30 seconds at annealing tem-
perature (5 °C below the melting point), and 1 to 3.5 min (ac-
cording to the size of the fragments) at 72 °C; 10 min at 72 °C; and
then storage at 4 °C. The nucleotide and predicted amino acid
sequences were analyzed using DNASTAR and compared with the
GenBank database using BLAST (http://www.ncbi.nlm.nih.gov/
BLAST/).
2.4. Construction of P. aeruginosa PAO1 and PA515 nor gene knock-
out mutants
Protocols for DNA manipulation, cloning, reporter strain con-
struction, and plasmid and chromosomal DNA puriﬁcations were
obtained from Sambrook et al. [16]. Enzymes were purchased from
either TaKaRa Japan or Promega USA. Two oligonucleotide primers
were designed on the basis of the sequences ﬂanking the nor
genes of P. aeruginosa [17]. The nor genes of P. aeruginosa were
ampliﬁed by PCR from chromosomal DNA using the primer com-
binations NorEF (GTAGAATTCCTGGTCTACGTCCTGCAATGAG) and
NorHR (GTGAAGCTTCCGATGAGGAACACCACCC). The ampliﬁed
fragments were subsequently cloned into pMD18-T (TaKaRa) and
sequenced. To avoid errors introduced by PCR, the DNA inserts
from three individual clones were sequenced and compared. The
nor genes consensus sequences from P. aeruginosa were compared
to the nitric oxide reductase genes available in the GenBank da-
tabase. For construction of the gene knockout mutants, a SacB-
based strategy was employed [18]. The PCR product of the norSource or
reference
dRMS-mcrBC), Φ 80
74 recA1 endA1
) 7697 galU galK λ-
Invitrogen
ain This study
ant, GmR This study
l strain Clinic
ant, GmR This study
l strain Clinic
l strain Clinic
l strain Clinic
replacement vector
ning site from pUC18,
[18]
m the R100.1 plasmid,
ination sequences
lasmid, SmR/SpcR
[28]
f Gmr cassette, GmR [29]
helper vector, KanR [19]
ining a nor fragment, This study
Gmr-lacZ fragment
nsert in the SphI site,
This study
amicin, KanR kanamycin.
Fig. 1. The effect of SNP on the growth and PCN of PAO1. (A) A growth test on
PAO1: a liquid culture of PAO1 was grown in LB medium at 37 °C and at 200 rpm for
18 h. The NO donor compound in LB was added to the medium at the desired
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primer sequences) and cloned into pEX18Amp. To construct the
nor mutant, the DNA fragment containing the Gmr-lacZ from
pZ1918Gm was inserted into the target genes. The ﬁnal plasmid,
named pEXB1lacZ, was veriﬁed by PCR and enzyme digestion.
pEXBlacZ was introduced into P. aeruginosa by triparental mating
[19], and nor was disrupted by integration of pEXBlacZ into the
chromosome. The bacterial strains and plasmids used in this study
are described in Table 1.
2.5. PCN assay
P. aeruginosa was inoculated into 1 L of LB medium and in-
cubated at 37 °C in a shaking incubator at 150 rpm. The blue-co-
lored broth (due to the presence of PCN) was transferred into 50-
ml Oakridge tubes and centrifuged at 10,000g for 20 min at 4 °C.
The supernatant was transferred to a separating funnel and mixed
with chloroform in a 1:1.5 (supernatant: chloroform) ratio. This
mixture was shaken well and maintained undisturbed for 5–
10 min to extract the PCN into the chloroform. The blue colored
chloroform layer with PCN formed below the aqueous layer in the
separating funnel was collected in a conical ﬂask protected from
light to prevent oxidation. This chloroform fraction was then
transferred to a 500-mL vacuum rotary ﬂask and concentrated in a
vacuum rotary evaporator at 40 °C. The vacuum concentrated PCN
fraction was puriﬁed using a silica gel column 3 cm in diameter
and 60 cm in length. The columnwas packed with silica (mesh size
100–200) and equilibrated using a methanol-chloroform solvent
system at a ratio of 1:1, and the concentrated PCN fraction was
loaded onto the column. Methanol:chloroform (1:1) was used as
the mobile phase to separate the PCN. The chloroform phase was
then added to 0.2 N HCl (0.2 mL), which produced a pink to deep
red color that is indicative of the presence of PCN [20]. The ab-
sorbance was measured at 520 nm, and the PCN concentrations
were calculated.
2.6. Statistical analysis
The statistical signiﬁcance for differences in this study was
based on Student's two-tailed t-test. Differences were considered
signiﬁcant when the P-value was less than 0.05.concentration. The OD600 values were determined every 2 h. (B) The PCN test on
PAO1: the PAO1 were seeded onto LB agar and exposed to the indicated con-
centration of SNP. After 14 h, the samples were scanned for the color of the med-
ium. (C) The PCN assay on PAO1: the medium was mixed with chloroform, and the
chloroform phase was then added to 0.2 N HCl. The absorbance was measured at
520 nm. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)3. Results
3.1. Effect of SNP on growth and PCN levels in P. aeruginosa
First, we tested the effect of the exogenous NO on growth. PAO1
was cultured in the presence of a range of concentrations (20, 60,
100, 140, 160 and 200 μM) of the NO donor SNP for the 18 h cul-
ture (Fig. 1A). Compared with the control (no SNP), the reduction
rates for 20 μM, 60 μM, 100 μM, 140 μM, 160 μM, and 200 μM
were 6.3%, 7.9%, 8.2%, 12.1%, 24.9%, and 25.8%, respectively. These
results showed that the growth reduction was not strong at SNP
concentrations below 100 μM. Then, we chose the SNP con-
centration below 100 μM for the PCN assay in which growth was
not strongly inhibited. We measured PCN levels at a range of SNP
concentrations (20, 40, 60, 80 and 100 μM). After the 18 h culture
period, the reduction rates for 20 μM, 40 μM, 60 μM, 80 μM, and
100 μM were 45.4%, 65.1%, 82.5%, 83.1%, and 83.5%, respectively
(Fig. 1B and C). The reduction ratios (PCN reduction:Growth re-
duction) were calculated, and the ratios for 20 μM, 60 μM, and
100 μM were 7.2, 10.5, and 9.7, respectively. From the results, we
chose 60 μM SNP as the treatment condition in the subsequent
tests because the maximum ratio was found at 60 μM SNP.
To examine whether the results were universal to other P.aeruginosa strains, four clinical strains were selected from Shaanxi
Province People's Hospital (Table 2). The growth and PCN levels
were examined. Similar to the results for PAO1 that showed 7.9%
lower growth with 60 μM SNP after 18 h culture, the growth re-
duction rates in the 4 clinical strains were 6.1% for PA515, 8.8% for
PA516, 5.2% for PA554, and 5.7% for PA914 (Fig. 2A). Similar to the
results for PAO1 (82.5% reduction of PCN), the reduction of PCN in
the 4 clinical strains exposed to 60 μM SNP for 18 h showed strong
reductions in PCN levels (PCN reduction rate: 78.3% for PA515,
89.1% for PA516, 76.0% for PA554, and 70.8% for PA914) (Fig. 2B).
The reduction ratios (PCN reduction:Growth reduction) were also
calculated. The ratios were 10.5 for PAO1, 12.8 for PA515, 10.1 for
PA516, 14.5 for PA554, and 12.4 for PA914.
Compared with PAO1, the clinical strains had the same trend
for PCN reduction with low, sublethal concentrations of NO. All of
the data are presented as the mean7SD (n¼4) and have been
validated 4 times by experiments that had similar results.
Table 2
List of clinical strains used in this study.
Strain Gender Age Source Diagnose
PA515 Male 63 Sputum Pulmonary infection, closed craniocerebral injury
PA516 Male 76 Sputum Aspiration pneumonia and coronary atherosclerotic heart disease, bottom wall myocardial infarction (mi), Parkinson’s disease, hy-
perplasia of prostate, neurogenic bladder, moderate anemia
PA554 Male 85 Sputum Cerebral infarction, lung infection repeatedly, carotid atherosclerosis, hypertension
PA914 Male 42 Urine Urinary tract infection, urinary bladder ﬁstula, postoperative rectal cancer, postoperative left renal cyst, hyperplasia of prostate
Fig. 2. Growth and PCN reduction of clinical P. aeruginosa strains with 60 μM SNP. (A) A growth test on clinical P. aeruginosa strains: a liquid culture of clinical strains was
grown in LB medium at 37 °C and at 200 rpm for 18 h. The 60 μM NO donor compound in LB was added to the medium. The OD600 values at 18 h were determined.
(B) The PCN assay on clinical P. aeruginosa strains: the medium was mixed with chloroform, and the chloroform phase was then added to 0.2 N HCl. The absorbance was
measured at 520 nm.
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out mutants
Based on the results for the exogenous NO, we tested the effect
of endogenous NO on PCN levels in P. aeruginosa. Considering that
the deletion of Nor lead to the accumulation of endogenous NO,
the test was conducted by constructing nor mutants. First, to ex-
amine whether the nor gene were universal to P. aeruginosa
strains, we analyzed the nor sequence in PAO1 and clinical strains
by PCR and sequencing, and the results showed that these strains
possessed the same nor gene sequences as PAO1. Considering the
restriction sites and the plasmid available, we chose to delete the
norBC gene. The gentamicin-resistance cassette was inserted into
the norBC region by homologous recombination, which resulted in
deletion of norB and norC. The restriction sites used for the con-
struction are shown (Fig. 3A). Five gentamicin-resistant clones
were analyzed by PCR (Fig. 3B). We designed 3 primers, including
two end sequences of the target fragment, and a sequence in the
replacement fragment. As shown in Fig. 3B, when PCR was con-
ducted with the two ends primers, on the agarose gel only wild
strains had the band, while the mutant strains and the plasmid
had no bands; when using the primer in the replacement frag-
ment for PCR, the result was reversed, and only mutant strains and
the plasmid had the target band, and the wild strain did not. Then,we conducted a resistance test (Fig. 3C), and only the mutant
strains carrying the resistance gene could grow in the resistance
medium. Finally, we sequenced the insert fragment and conﬁrmed
that the norBC region was correctly replaced by Gm resistance
gene in all of the clones. One of these clones was named PAN1 (nor
mutant) and used for the subsequent experiments. To examine
whether the results were universal for the other P. aeruginosa
strains, we chose one of the clinical strains (PA515) to construct
the nor mutant strain (PAN515) using the same procedure.
3.3. Effect of NOR enzyme deletions on the growth and PCN levels of
P. aeruginosa
Based on the construction of the nor mutants, we ﬁrst tested
the growth of the PAO1 wild-type and nor mutants. The growth
curves of the PAO1 wild-type and nor mutants for 22 h are shown
in Fig. 4A. The difference in growth began at the exponential phase
and was 14% at the end of this phase. In the stagnate phase, the
difference decreased; the minimum difference was 6% at 18 h, and
the maximum difference was 10% at 22 h. In the whole culture, the
nor mutants grew slightly slower than the wild-type. The same
growth test was carried out in PA515 wild-type and nor mutants
(Fig. 4B). The difference in growth began at the exponential phase,
which was 8% at the end of this phase. However, unlike PAO1, in
Fig. 3. PCR and antibiotic resistance test. (A) A construction of the norBC mutant strain of P. aeruginosa. The gentamicin-resistance cassette was inserted into the norBC region
by homologous recombination, which resulted in total deletion of norB and partial deletion of norC. The restriction sites used for the construction are shown. GmR,
gentamicin resistance. (B) The PCR test: Lane 1: the PCR product of pEXB1lacZ using the NOREF/NORHR primer; Lane 2: the PCR product of PAN1 using the NOREF/NORHR
primer; Lane 3: the PCR product of the PAN1 (parallel sample) strain using the NOREF/NORHR primer; Lane 4: the PCR product of PAO1 using the NOREF/NORHR primer;
Lane 5: Marker; Lane 6: the PCR product of pEXB1lacZ using the lacZ-F/NORHR primer; Lane 7: the PCR product of PAN1 using the lacZ-F/NORHR primer; Lane 8: the PCR
product of PAN1 (parallel sample) using the lacZ-F/NORHR primer; Lane 9: the PCR product of PAO1 using the lacZ-F/NORHR primer; (C) The antibiotic resistance test: (C1)
growth of PAO1 and its disruption mutants on PIA medium containing Gm (only PAN1 could grow); and (C2) growth of PAO1 and its disruption mutants on PIA medium (no
antibiotic was added, and all of the strains could grow well on it).
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ference was maintained at approximately 8% until 22 h. From the
results, it is clear that the nor gene did not have a strong effect on
growth.
Then, we compared the levels of the PCN of PAO1 wild-type and
nor mutants (Fig. 5A). After the 6 h culture, the two strains exhibited
normal color with hardly any PCN. However, after 8 h, the PCN in the
nor mutants was signiﬁcantly lower than that in the wild-type. The
PCN difference strictly increased until 18 h. After 18 h, the difference
was maintained, and the maximum PCN reduction observed was 86%
in PAN1 compared to PAO1 at 22 h (Fig. 5A). The same PCN test was
conducted on PA515 wild-type and nor mutants. After a 6 h culture,
the two strains exhibited normal color with hardly any PCN. After
8 h, the PCN in the nor mutants was signiﬁcantly lower than that in
the wild-type. However, unlike PAO1, the PCN difference strictly in-
creased until 24 h. The observed PCN reduction was 85.2% in PAN515compared to the PA515 at 22 h (Fig. 5B). The reduction ratio (PCN
reduction: growth reduction) was also calculated. The ratios were
8.6 for PAN1 and 10.6 for PAN515.
The results show that the PCN biosynthesis weakened the NOR-
deﬁcient mutants when compared with wild-type strains. All of
the data are presented as the mean7SD (n¼4) and have been
validated 4 times by experiments with similar results.4. Discussion
PCN not only interferes with multiple cellular functions, it is
also required in P. aeruginosa clinical infections, which can kill lung
epithelial cells [7]. One of the strategies to overcome P. aeruginosa
virulence is to inhibit PCN biosynthesis by antioxidant therapy that
neutralizes PCN-generated oxidative stress [21]. Smith et al.
Fig. 4. The effect of Nor on the growth of PAO1 and PA515. (A) The growth test for
PAO1 and PAN1: liquid cultures of PAO1 and PAN1 were grown in LB medium at
37 °C and at 200 rpm for 22 h. OD600 values were determined every 2 h. (B) The
growth test for PA515 and PAN515: liquid cultures of PA515 and PAN515 were
grown in LB medium at 37 °C and at 200 rpm for 22 h. The OD600 values were
determined every 2 h.
Fig. 5. The effect of Nor on the PCN produced by PAO1 and PA515. A. The PCN assay
for PAO1 and PAN1: liquid cultures of PAO1 and PAN1 were grown in LB medium at
37 °C and at 200 rpm for 24 h. The medium was mixed with chloroform, and the
chloroform phase was then added to 0.2 N HCl. The absorbance was measured at
520 nm. B. The PCN assay for PA515 and PAN515: liquid cultures of PA515 and
PAN515 were grown in LB medium at 37 °C and at 200 rpm for 24 h. The medium
was mixed with chloroform, and the chloroform phase was then added to 0.2 N
HCl. The absorbance was measured at 520 nm. C: A picture of PCN in the chloro-
form layer (PAO1: left; PAN1: right). (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of this article.)
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PCN therapy [22].
In this study, we investigated the effect of NO on PCN bio-
synthesis in P. aeruginosa. Unlike the minor effect on growth at a
range of SNP concentrations (20–100 μM), the PCN biosynthesis
was strongly inhibited with the increase in SNP. This trend was
similar in PAO1 (the mode strain of P. aeruginosa) and 4 clinical
strains (PCN reduction: 82.5% in PAO1, 78.3% in PA515, 89.1% in
PA516, 76.0% in PA554, and 70.8% in PA914). Furthermore, we
observed up to an 82.5% reduction in PCN biosynthesis with the
60 μM NO donor, whereas the reported reduction via other
compounds was lower: 50% reduction with catechin (2–4 mM)
[23], 56% with eugenol (at 50–400 μM) [24], and 76.5% with
2.5 g/L of Yunnan Baiyao, which is a well-known Chinese her-
bal medicine [25]. The results suggest that NO exerts better
anti-virulence activity by interfering with PCN biosynthesis
in P. aeruginosa.
In addition to the exogenous compound, some research shows
that deleting certain genes can inhibit PCN biosynthesis. ΔBpiB09
(an NADP-dependent reductase) mutants reportedly produce up to
75% lower PCN than the wild-type after 16 h of growth [26]. In this
study, we analyzed the effect of the nor gene, which coded the
nitric oxide reductase, on PCN biosynthesis. Nitric oxide reductase
is a key enzyme that catalyzes endogenous NO and reduces it to
N2O. The deletion of norwill induce endogenous NO accumulation.
We ﬁrst analyzed the nor sequence in clinical strains (Table 2) by
PCR and gene sequencing, and the results showed that these
strains processed the same nor gene sequences, such as PAO1,
which suggested that the nor sequence in P. aeruginosa is con-
servative. Then, the effects of endogenous NO on PCN in P. aeru-
ginosa were tested by constructing NOR-deﬁcient mutants. Our
results showed that PCN biosynthesis was weakened in the NOR-
deﬁcient mutants (86% reduction in PAN1, 85.2% in PAN515) when
compared with the wild-type strains. These results indicate that
the accumulation of endogenous NO by deleting nor strongly in-
hibits PCN biosynthesis in P. aeruginosa.
In summary, both exogenous and endogenous NO can sig-
niﬁcantly reduce PCN production in P. aeruginosa as well as in
clinical strains. These results suggest that we may use an NO donor
or selective inhibition of NOR to eliminate P. aeruginosa virule-
nce through inhibition of PCN biosynthesis. Further studies are
required to determine the speciﬁc molecular mechanism involved.
Previous studies have shown that NO participates in diverse bio-
logical processes [27]. It acts through redox-based modiﬁcation of
cysteine residue(s) of target proteins, called protein S-nitrosation.
Seth et al. have demonstrated that S-nitrosylation of OxyR under
anaerobic condition in E. coil can activate hcp transcription to
protect against endogenous nitrosative stress [14]. PCN is syn-
thesized through a series of complex steps including gene ex-
pression and modiﬁcation from precursors into the tricyclic com-
pound mediated by many key enzymes [3]. We have found that
total protein S-nitrosation signiﬁcantly increased when P. aerugi-
nosa are exposed to NO (data not shown). We speculate that some
proteins involving in PCN biosynthesis might be modiﬁed by NO,
which is perhaps crucial to the PCN reduction. Further investiga-
tion is undergoing.Acknowledgments
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